Dr. Crafton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4815 Liberty Avenue
Suite 310
Pittsburgh, PA 15224Phone+1 412-578-1116Fax+1 412-605-6396
Education & Training
- Ohio State University/Mt Carmel HospitalFellowship, Gynecologic Oncology, 2015 - 2018
- Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 2011 - 2015
- University of AkronMaster's Certificate, Women's Studies, 2008 - 2011
- Northeast Ohio Medical UniversityClass of 2011
- Youngstown State UniversityB.S., Combined Science, 2004 - 2007
Certifications & Licensure
- OH State Medical License 2011 - 2025
- PA State Medical License 2018 - 2024
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Gold Humanism Honor Society NEOMED, 2011
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2021 Sep 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Clinical outcomes with utilization of high-potency topical steroids in patients with lichen sclerosus-associated vulvar cancer.Nujsaubnusi C Vue, Jessica Sassani, Beth Prairie, Yue Yin, Thomas C Krivak
Gynecologic Oncology. 2024-08-01 - A review of the state of cervical cancer: updates from prevention to recurrent disease.Sarah M Crafton, Puja S Venkat, Ritu Salani
Current Opinion in Obstetrics & Gynecology. 2024-02-01 - 3 citationsA phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi
International Journal of Gynecological Cancer. 2023-09-04
Press Mentions
- Dr. Crafton on Considerations for Secondary Cytoreduction in Ovarian CancerFebruary 18th, 2020
- Dr. Crafton on the Impact of PARP Inhibitors in Recurrent Ovarian CancerDecember 20th, 2019
- The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024
Professional Memberships
- Fellow
- Society of Gynecologic OncologyMember
External Links
- Allegheny Health Networkhttps://doctors.ahn.org/Sarah-Crafton
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: